Trial · NCT01467362
Efficacy Emollient on Xerosis in Children With Atopic Dermatitis
NCT01467362, Phase 3, Completed, Pierre Fabre Medicament
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Efficacy Emollient on Xerosis in Children With Atopic Dermatitis. Trials, record NCT01467362. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT01467362
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Efficacy Emollient on Xerosis in Children With Atopic Dermatitis
- NCT number
- NCT01467362
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 251 participants, actual
- Lead sponsor
- Pierre Fabre Medicament
- Conditions
- Atopic Dermatitis
- Interventions
- V0034CR01B, Vehicle cream, desonide 0.1% cream, Foaming gel
- First posted
- 2011-11-08
- Last updated
- 2013-02-21
- Other registries' IDs
- eudract:2011-003295-37
Source ClinicalTrials.gov
Registered outcomes9
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Xerosis score: mean evolution over the different time-points of double-blind period | During 28 days (Day 1, Day 7, Day 14, Day 21 and Day 28) | |
| Secondary | Hydration Index score : measurement of the skin hydration | Day 1, Day 14, Day 28, Day 56 and Day 84 | |
| Secondary | Xerosis score evolution over the different time-ponts during open label period | At Visit1 (Day 1) and at Day 56 and Day 84 | |
| Secondary | Xerosis Visual Analogue Scale (evaluation skin dryness) | Day 1, Day 14, Day 28, Day 56 and Day 84 | |
| Secondary | Scoring for Atopic Dermatitis (SCORAD) : measurement of objective symptoms of Atopic Dermatitis. | Day1, Day 28, Day 56 and Day 84. | |
| Secondary | Overall assessment of treatment efficacy by the investigator | Day 28 and Day 84 | |
| Secondary | Overall assessment of treatment efficacy and use by the parent(s)/guardian(s) | at Day 28 and at Day 84 | |
| Secondary | Assessment of the local tolerability and the systemic safety (reported adverse events) | Day 1, Day 7, Day 14, Day 21, Day 28, Day 56 and Day 84 | |
| Secondary | Topical corticosteroid assessment | Day 7, Day 14, Day 21, Day 28, Day 56 and Day 84 |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT01467362
GET https://conductscience.org/api/trials/v1/NCT01467362/registered